• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外血液净化中的内毒素吸附剂:它们是否符合预期?

Endotoxin adsorbents in extracorporeal blood purification: do they fulfill expectations?

作者信息

Harm Stephan, Falkenhagen Dieter, Hartmann Jens

机构信息

Department for Health Sciences and Biomedicine, Danube University Krems, Krems - Austria.

出版信息

Int J Artif Organs. 2014 Mar;37(3):222-32. doi: 10.5301/ijao.5000304. Epub 2014 Apr 4.

DOI:10.5301/ijao.5000304
PMID:24744167
Abstract

INTRODUCTION

Lipopolysaccharides (LPS) are extremely strong stimulators of inflammatory reactions, act at very low concentrations, and are involved in the pathogenesis of sepsis and septic shock. Because of its toxicity, the efficient removal of endotoxin from patients' blood is very important in clinical medicine. The purpose of this study was to determine the endotoxin adsorption capacities of commercial endotoxin adsorbers for endotoxin removal in buffer solution, protein solution, serum and heparinized plasma; some of these were also characterized in whole blood. The tested LPS adsorbers were Toraymyxin® PMX-20R, Alteco® LPS Adsorber, DEAE-Sepharose, Polymyxin B-Agarose, and EndoTrap® red.

METHODS

The adsorber materials were tested in buffer and protein solutions spiked with fluorescently labeled LPS (100 ng/ml). Additionally, batch tests with LPS-spiked serum, heparinized plasma and whole blood were performed with an LPS concentration of 5 ng/ml. Additionally, the washing solutions of the two tested Polymyxin B (PMB)-based adsorbers were analyzed for PMB release to determine if the resulting LPS inactivation was caused by PMB leakage.

RESULTS

The results show that DEAE-Sepharose was most effective in LPS adsorption. Of the other tested endotoxin removal materials, only the PMB-based adsorbers were able to reduce the LPS activity. However, we were able to show that the reduction in LPS activity was caused by desorbed PMB, which inactivates endotoxins.

CONCLUSIONS

None of the adsorbents that were tested in this study showed promising results for potential use in extracorporeal blood purification.

摘要

引言

脂多糖(LPS)是炎症反应的极强刺激物,在极低浓度下即可发挥作用,并参与脓毒症和脓毒性休克的发病机制。由于其毒性,在临床医学中从患者血液中有效去除内毒素非常重要。本研究的目的是测定市售内毒素吸附剂在缓冲溶液、蛋白质溶液、血清和肝素化血浆中去除内毒素的吸附能力;其中一些还在全血中进行了特性分析。所测试的LPS吸附剂包括Toraymyxin® PMX - 20R、Alteco® LPS吸附剂、二乙氨基乙基琼脂糖(DEAE - Sepharose)、多粘菌素B - 琼脂糖(Polymyxin B - Agarose)和EndoTrap® red。

方法

将吸附剂材料在添加了荧光标记LPS(100 ng/ml)的缓冲溶液和蛋白质溶液中进行测试。此外,还对添加了LPS(浓度为5 ng/ml)的血清、肝素化血浆和全血进行了批量测试。另外,对两种测试的基于多粘菌素B(PMB)的吸附剂的洗涤液进行分析,以确定PMB的释放情况,从而判断由此导致的LPS失活是否是由PMB泄漏引起的。

结果

结果表明,DEAE - Sepharose在LPS吸附方面最为有效。在其他测试的内毒素去除材料中,只有基于PMB的吸附剂能够降低LPS活性。然而,我们能够证明LPS活性的降低是由解吸的PMB引起的,PMB可使内毒素失活。

结论

本研究中测试的吸附剂均未显示出在体外血液净化中具有潜在应用的良好前景。

相似文献

1
Endotoxin adsorbents in extracorporeal blood purification: do they fulfill expectations?体外血液净化中的内毒素吸附剂:它们是否符合预期?
Int J Artif Organs. 2014 Mar;37(3):222-32. doi: 10.5301/ijao.5000304. Epub 2014 Apr 4.
2
Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.腹部感染性休克 - 内毒素吸附治疗(ASSET) - 使用Alteco® LPS吸附剂清除腹部和泌尿生殖系统感染性休克中的内毒素:一项双盲、随机、安慰剂对照试验的研究方案
Trials. 2016 Dec 8;17(1):587. doi: 10.1186/s13063-016-1723-4.
3
Novel Insights into the Direct Removal of Endotoxin by Polymyxin B Hemoperfusion.新型洞察:多黏菌素 B 血液灌流直接清除内毒素。
Blood Purif. 2017;44(3):193-197. doi: 10.1159/000475982. Epub 2017 Jun 10.
4
[Experience of using endotoxin selective adsorption in patients with severe sepsis after open-heart surgery].[心脏直视手术后严重脓毒症患者使用内毒素选择性吸附的经验]
Anesteziol Reanimatol. 2014 May-Jun(3):39-46.
5
Endotoxin adsorption using polymyxin B immobilized fiber cartridges in severe sepsis patients following cardiac surgery.心脏手术后严重脓毒症患者使用多粘菌素B固定化纤维柱进行内毒素吸附
Int J Artif Organs. 2014 Apr;37(4):299-307. doi: 10.5301/ijao.5000322. Epub 2014 Apr 16.
6
Efficacy of a novel endotoxin adsorber polyvinylidene fluoride fiber immobilized with (L)-serine ligand on septic pigs.新型内毒素吸附剂聚偏氟乙烯纤维固定化 L-丝氨酸配体对脓毒症猪的疗效。
J Zhejiang Univ Sci B. 2011 Apr;12(4):264-72. doi: 10.1631/jzus.B1000389.
7
A true theranostic approach to medicine: towards tandem sensor detection and removal of endotoxin in blood.医学上真正的治疗策略:实现血液中内毒素的串联传感器检测和清除。
Biosens Bioelectron. 2015 May 15;67:3-10. doi: 10.1016/j.bios.2014.07.008. Epub 2014 Jul 9.
8
Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.使用固定多粘菌素B的纤维吸附柱进行直接血液灌流去除内毒素可改善感染性休克患者的全身循环障碍。
Am J Kidney Dis. 2002 May;39(5):937-47. doi: 10.1053/ajkd.2002.32767.
9
Mechanisms of polymyxin B endotoxin removal from extracorporeal blood flow: molecular interactions.从体外血流中去除多粘菌素B内毒素的机制:分子相互作用
Contrib Nephrol. 2010;167:45-54. doi: 10.1159/000315918. Epub 2010 Jun 1.
10
Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.使用多粘菌素B固定化纤维(PMX)治疗脓毒症休克的内毒素吸附疗法:通过高灵敏度内毒素测定和细胞因子产生能力测量进行评估
Ther Apher Dial. 2006 Feb;10(1):12-8. doi: 10.1111/j.1744-9987.2006.00340.x.

引用本文的文献

1
Insights into the Binding Mode of Lipid A to the Anti-lipopolysaccharide Factor ALFPm3 from : An In Silico Study through MD Simulations.通过分子动力学模拟研究脂多糖结合蛋白 ALFPm3 与脂多糖结合模式的深入了解:一项计算机模拟研究
J Chem Inf Model. 2023 Apr 24;63(8):2495-2504. doi: 10.1021/acs.jcim.3c00173. Epub 2023 Apr 7.
2
Advances in the Development of Biomaterials for Endotoxin Adsorption in Sepsis.脓毒症中用于内毒素吸附的生物材料的发展进展
Front Bioeng Biotechnol. 2021 Jul 30;9:699418. doi: 10.3389/fbioe.2021.699418. eCollection 2021.
3
LDL apheresis as an alternate method for plasma LPS purification in healthy volunteers and dyslipidemic and septic patients.
LDL 吸附法作为健康志愿者及脂代谢紊乱和脓毒症患者血浆 LPS 净化的替代方法。
J Lipid Res. 2020 Dec;61(12):1776-1783. doi: 10.1194/jlr.RA120001132. Epub 2020 Oct 9.
4
[Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab].6例接受血浆置换或托珠单抗治疗的重症新型冠状病毒肺炎患者的临床观察
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):227-231. doi: 10.3785/j.issn.1008-9292.2020.03.06.
5
Blood Compatibility-An Important but Often Forgotten Aspect of the Characterization of Antimicrobial Peptides for Clinical Application.血液相容性——抗菌肽临床应用特性评价中一个重要但常被忽视的方面。
Int J Mol Sci. 2019 Oct 31;20(21):5426. doi: 10.3390/ijms20215426.
6
The Use of Endotoxin Adsorption in Extracorporeal Blood Purification Techniques. A Case Report.内毒素吸附在体外血液净化技术中的应用。病例报告。
J Crit Care Med (Targu Mures). 2017 May 11;3(2):73-78. doi: 10.1515/jccm-2017-0010. eCollection 2017 Apr.
7
In vitro comparison of the adsorption of inflammatory mediators by blood purification devices.血液净化装置对炎症介质吸附作用的体外比较
Intensive Care Med Exp. 2018 May 4;6(1):12. doi: 10.1186/s40635-018-0177-2.
8
An essential role of high-molecular-weight kininogen in endotoxemia.高分子量激肽原在内毒素血症中的重要作用。
J Exp Med. 2017 Sep 4;214(9):2649-2670. doi: 10.1084/jem.20161900. Epub 2017 Aug 9.
9
Low-dose polymyxin: an option for therapy of Gram-negative sepsis.低剂量多粘菌素:革兰氏阴性菌败血症治疗的一种选择。
Innate Immun. 2016 May;22(4):274-83. doi: 10.1177/1753425916639120. Epub 2016 Mar 17.
10
Efficient removal of colistin A and B in critically ill patients undergoing CVVHDF and sorbent technologies.在接受连续性静脉-静脉血液透析滤过(CVVHDF)及吸附剂技术治疗的重症患者中高效去除黏菌素A和B
J Nephrol. 2015 Oct;28(5):623-31. doi: 10.1007/s40620-014-0143-3. Epub 2014 Sep 24.